EUVIMEDEUVIMED entdecken
Crossref

Alkaline Phosphatase-To-Albumin Ratio (APAR) As A Prognostıc Biomarker in Metastatic Hormone-Sensitive Prostate Cancer

Faruk Recep Özalp, Ahmet Melih Arslan, Özge Yetginoğlu, Hüseyin Salih Semiz

Journal of Basic and Clinical Health Sciences · 31.05.2026 · 10 (2) · 222-228

DOI: 10.30621/jbachs.1834209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Basic and Clinical Health Sciences, online erschienen am 31.05.2026. Verfasst von Faruk Recep Özalp und 3 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metastatic hormone-sensitive prostate cancer (mHSPC) requires accessible biomarkers for better prognostication. This study investigated the prognostic value of the alkaline phosphatase-to-albumin ratio (APAR) in mHSPC survival risk stratification.

Methods

We retrospectively analyzed 128 mHSPC patients. A cut-off of 2.92 for APAR was determined via ROC analysis. Overall survival (OS) was assessed using Kaplan–Meier methods and multivariable Cox regression adjusting for standard prognostic factors, including tumor volume and Gleason score.

Results

Patients with APAR ≥2.92 had significantly shorter OS compared to those with APAR

Zitieren

APA

Özalp, F. R., Arslan, A. M., Yetginoğlu, Ö., & Semiz, H. S. (2026). Alkaline Phosphatase-To-Albumin Ratio (APAR) As A Prognostıc Biomarker in Metastatic Hormone-Sensitive Prostate Cancer. Journal of Basic and Clinical Health Sciences, 10(2), 222-228. https://doi.org/10.30621/jbachs.1834209

Vancouver

Özalp FR, Arslan AM, Yetginoğlu Ö, Semiz HS. Alkaline Phosphatase-To-Albumin Ratio (APAR) As A Prognostıc Biomarker in Metastatic Hormone-Sensitive Prostate Cancer. Journal of Basic and Clinical Health Sciences. 2026;10(2):222-228. doi:10.30621/jbachs.1834209

BibTeX
@article{zalp2026,
  author = {Özalp, Faruk Recep and Arslan, Ahmet Melih and Yetginoğlu, Özge and Semiz, Hüseyin Salih},
  title = {Alkaline Phosphatase-To-Albumin Ratio (APAR) As A Prognostıc Biomarker in Metastatic Hormone-Sensitive Prostate Cancer},
  journal = {Journal of Basic and Clinical Health Sciences},
  year = {2026},
  volume = {10},
  number = {2},
  pages = {222--228},
  doi = {10.30621/jbachs.1834209}
}
Kostenlos starten →